News & Events about Zoetis Inc.
Zoetis Inc. (NYSE:ZTS Get Rating) has been given an average recommendation of Moderate Buy by the eight analysts that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a hold rating and seven have given a buy rating to the...
Courier Capital LLC bought a new stake in shares of Zoetis Inc. (NYSE:ZTS Get Rating) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 1,907 shares of the companys stock, valued at approximately $283,000. A ...
Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Tuesday, Feb. 14, 2023. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review fourth quarter and full year 2022 financial results and respond to...
Zoetis Inc. (NYSE:ZTS) will participate in the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023. Kristin Peck, Chief Executive Officer, will represent the company and respond to questions from analysts. She is scheduled to present at 1:30 p.m. PT. Investors and other...
Zoetis Inc. (NYSE:ZTS) will participate in the Piper Sandler 34th Annual Healthcare Conference on Wednesday, November 30, 2022. Glenn David, Executive Vice President and Group President, U.S. Operations, Global Diagnostics and BioDevices, will represent the company and respond to questions from...